Summary

Colchicine for the treatment of COVID-19

Agata Mikolajewska1, Anna-Lena Fischer2, Vanessa Piechotta3, Anika Mueller4, Maria-Inti Metzendorf5, Marie Becker6, Elena Dorando3, Rafael L Pacheco7-9, Ana Luiza C Martimbianco7,9-11, Rachel Riera9,11,12, Nicole Skoetz13, Miriam Stegemann1

Affiliation of the authors

1Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany. 2Department of Anaesthesia and Intensive Care, Universitätsklinikum Leipzig, 04103 Leipzig, Germany. 3Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. 4Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 5Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. 6Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. 7Center of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brasil. 8Núcleo de Ensino e Pesquisa em Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde (NEP-Sbeats), Universidade Federal de São Paulo, São Paulo, Brasil. 9Cochrane AOiliate Rio de Janeiro, Cochrane, Petrópolis, Brasil. 10Postgraduate Program in Health and Environment, Universidade Metropolitana de Santos (UNIMES), Santos, Brasil. 11Núcleo de Ensino e Pesquisa em Saúde Baseada em Evidências e Avaliação de Tecnologias em Saúde (NEP-Sbeats), Universidade Federal de São Paulo, São Paulo, Brasil. 12Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brasil. 13Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

DOI

Quote

Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, et al. Colchicine for the treatment of COVID-19. Emergencias. 2023;35:300-2

More articles by the authors